Nationwide prevalence and characteristics of transthyretin amyloid cardiomyopathy in Sweden
Guardado en:
Autores principales: | J Gustav Smith, Johanna Kuusisto, Einar Gude, Rosa Elisabeth Lauppe, Johan Liseth Hansen, Christian Gerdesköld, Mark H Rozenbaum, Anne Mette Strand, Merja Vakevainen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60d995de3d9740c2b7475b1486e30acc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy
por: Ahsan Huda, et al.
Publicado: (2021) -
Stochastic master equation for early protein aggregation in the transthyretin amyloid disease
por: Ruo-Nan Liu, et al.
Publicado: (2020) -
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
por: Aubin Michalon, et al.
Publicado: (2021) -
Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin
por: Genki Suenaga, et al.
Publicado: (2017) -
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Silvia Oghina, et al.
Publicado: (2021)